What is the catalog number for Triptolide-d3?

The catalog number for Triptolide-d3 is HY-32735S.

What sizes are available for Triptolide-d3?

Triptolide-d3 is available in the following size(s): 1 mg.

Is Triptolide-d3 in stock?

Triptolide-d3 is currently made to order / not held in immediate stock. Contact us for lead time.

Who manufactures Triptolide-d3?

Triptolide-d3 is manufactured by QuantiMol.

What is the estimated delivery time for Triptolide-d3?

Estimated delivery time for Triptolide-d3 is approximately 15 business day(s), depending on your location.

Where can I find the safety data sheet (SDS/MSDS) for Triptolide-d3?

The safety data sheet for Triptolide-d3 is available here: http://file.medchemexpress.com/batch_PDF/HY-32735S/Triptolide-d3-SDS-MedChemExpress.pdf.

Triptolide-d3

Triptolide-d3 is the deuterium labeled Triptolide. Triptolide is a diterpenoid triepoxide extracted from the root of Tripterygium wilfordii with immunosuppressive, anti-inflammatory, antiproliferative and antitumour effects. Triptolide is a NF-κB activation inhibitor[1][2][3][4][5][6].

Product Specifications

Product Name Alternative

PG490-d3

UNSPSC

12352005

Hazard Statement

H302, H315, H319, H335

Target

Apoptosis; Isotope-Labeled Compounds; NF-κB

Type

Isotope-Labeled Compounds

Related Pathways

Apoptosis; NF-κB; Others

Field of Research

Cancer

Purity

91.99

Solubility

DMSO : 25 mg/mL (ultrasonic; warming)

Smiles

C[C@@]12[C@@]34[C@]5([C@@H]([C@@]6([C@](O6)([H])[C@]3([H])O4)C(C)C)O)[C@@](C[C@@]1([2H])C7=C(C(OC7([2H])[2H])=O)CC2)([H])O5

Molecular Formula

C20H21D3O6

Molecular Weight

363.42

Precautions

H302, H315, H319, H335

References & Citations

[1]Russak EM, et al. Impact of Deuterium Substitution on the Pharmacokinetics of Pharmaceuticals. Ann Pharmacother. 2019;53 (2) :211-216. |[2]Ganguly S, et al. Targeting HSF1 disrupts HSP90 chaperone function in chronic lymphocytic leukemia. Oncotarget. 2015 Oct 13;6 (31) :31767-79.|[3]Huang M, et al. Triptolide inhibits MDM2 and induces apoptosis in acute lymphoblastic leukemia cells through a p53-independent pathway. Mol Cancer Ther. 2013 Feb;12 (2) :184-94.|[4]Xu P, et al. Triptolide Inhibited Cytotoxicity of Differentiated PC12 Cells Induced by Amyloid-Beta25-35 via the Autophagy Pathway. PLoS One. 2015 Nov 10;10 (11) :e0142719.|[5]Kong LL, et al. Inhibition of P-glycoprotein Gene Expression and Function Enhances Triptolide-induced Hepatotoxicity in Mice. Sci Rep. 2015 Jul 2;5:11747.|[6]Zhang W, et al. Triptolide Combined with Radiotherapy for the Treatment of Nasopharyngeal Carcinoma via NF-κB-Related Mechanism. Int J Mol Sci. 2016 Dec 19;17 (12) . pii: E2139.|[7]Cai J, et al. Natural product triptolide induces GSDME-mediated pyroptosis in head and neck cancer through suppressing mitochondrial hexokinase-ΙΙ. J Exp Clin Cancer Res. 2021;40 (1) :190. Published 2021 Jun 9.